Thursday, October 11, 2018TOBACCO
16K New Tobacco Industry Documents Posted15,957 tobacco documents
were added to the Truth Tobacco Industry Documents today
Catch up on additions to the Bibliography (papers/publications using tobacco industry documents):
Benson,T. Big Tobacco Already Eyeing Pot
, Rolling Stone, 2018.
Ling,P; Glantz,S. Tobacco company strategies to identify and promote the benefits of nicotine
. Tobacco Control, 2018.
Hawkins,B.;McCambridge,J. Can internal tobacco industry documents be useful for studying the UK alcohol industry?
BMC Public Health, 2018.
Apollonio,D.E.;Glantz,S.A. Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents
Tobacco Control, 2018.
Elias,J; Ling,PM. Invisible smoke: third-party endorsement and the resurrection of heat-not-burn tobacco products
. Tobacco Control, 2018.
Persoskie,A.;Donaldson,E.A.;Ryant,C. How tobacco companies have used package quantity for consumer targeting
. Tobacco Control, 2018.
Elias J; Hendlin Y; Ling P. Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents
. PLoSMed, 2018.
van der Eijk,Y.; Bialous,S.A.; Glantz,S. The Tobacco Industry and Children's Rights
. Pediatrics, 2018.
Thursday, August 16, 2018CHEMICALTOBACCO
800+ New Tobacco and Chemical Industry Documents Posted
New documents have been added to the Truth Tobacco Industry Documents and the Chemical Industry Documents Archive:
394 new Agrichemical Industry documents representing additional documents acquired from the Monsanto Roundup cancer cases as well as documents acquired via FOIA requests to the EPA and FDA concerning glyphosate.
Monday, July 23, 2018DRUG
Pinnacle Hip Replacement Litigation Documents Online
The UCSF Drug Industry Documents Archive (DIDA) is please to announce the Pinnacle Litigation Documents, a new collection of documents from the MDL lawsuit DePuy Orthopaedics Inc. Pinnacle Hip Implant Products Liability Litigation.
From 2002 to 2012, DePuy Orthopaedics, a subsidiary of Johnson & Johnson (J&J), manufactured metal-on-metal (MoM) hip implants sold under the brand name Pinnacle. The lawsuit charged the hip implant was defectively designed and fraudulently marketed and that DePuy failed to warn patients and doctors about the risks of the devices. Prosecutors claimed that DePuy, in an effort to gain and keep a large share of the hip replacement market, rushed the Pinnacle metal-on-metal hip implant to market without ever testing it in humans. Instead, the company used a loophole known as the FDA's 510(k) regulatory pathway. The 510(k) allowed manufacturers to skip clinical trials and test the implants only on mechanical simulators if they could show the implants were 'substantially equivalent' to other devices already in use.
The plaintiffs in the Pinnacle lawsuits experienced high levels of cobalt and metal ion in their systems, a condition called metallosis, due to the wear from the surface of the implant’s femoral head. Ultimately, many of these hip implants failed and had to be replaced. In addition to defective design and health risks, the suit charged DePuy fraudulently marketed the Pinnacle hip replacement system by using a team of 'design surgeons' as a sales force. Called KOLs (key opinion leaders), these surgeons signed off on ghostwritten articles, hosted speaking engagements and large regional sales meetings, and taught other surgeons how to use the Pinnacle system. In return, documents show these design surgeons received millions of dollars in royalties from the sales of the Pinnacle hip replacement system.
Monday, July 23, 2018TOBACCO
More Tobacco Depositions and Trial Testimony posted
A new set of deposition and trial testimony transcriptss
as well as a few new industry documents were posted to the Truth Tobacco Industry Documents Library. The court transcripts and depositions were donated by Robert Proctor, PhD.
Thursday, June 21, 2018DRUGTOBACCO
New Tobacco and Drug Industry Documents Posted345 new documents
were added to the Truth Tobacco Industry Documents library today.
New Collection of Cymbalta Litigation Documents
This set of documents comes from the MSJ: Hagan-Brown & Ali v. Eli Lilly and Company; Case No. 1:14-cv-01614-AJT-JFA
The case alleges Lilly omitted important information about the drug’s withdrawal risks in the company’s labeling and marketing materials and therefore consumers were unable to make an informed choice about whether to take Cymbalta.
Monday, June 04, 2018CHEMICAL
New collection of documents on the U.S. EPA and chlorpyrifos
The UCSF Chemical Industry Documents Archive (CIDA) is pleased to post the 'NY Times EPA Collection
This collection contains sets of documents obtained by the New York Times through state public records requests and FOIA requests during their investigations into the EPA's recent organizational changes and shift on toxic chemicals, including the 2017 decision to reject a ban on chlorpyrifos, a widely used pesticide.